296 related articles for article (PubMed ID: 27412504)
1. B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.
Piancone F; Saresella M; Marventano I; La Rosa F; Zoppis M; Agostini S; Longhi R; Caputo D; Mendozzi L; Rovaris M; Clerici M
Sci Rep; 2016 Jul; 6():29699. PubMed ID: 27412504
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.
Huarte E; Jun S; Rynda-Apple A; Golden S; Jackiw L; Hoffman C; Maddaloni M; Pascual DW
J Immunol; 2016 Jun; 196(12):5036-46. PubMed ID: 27194787
[TBL] [Abstract][Full Text] [Related]
3. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis.
Kim Y; Kim G; Shin HJ; Hyun JW; Kim SH; Lee E; Kim HJ
J Neuroinflammation; 2018 Oct; 15(1):300. PubMed ID: 30373595
[TBL] [Abstract][Full Text] [Related]
4. Blimp-1 Contributes to the Development and Function of Regulatory B Cells.
Wang YH; Tsai DY; Ko YA; Yang TT; Lin IY; Hung KH; Lin KI
Front Immunol; 2019; 10():1909. PubMed ID: 31474988
[TBL] [Abstract][Full Text] [Related]
5. Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Blumenfeld S; Staun-Ram E; Miller A
J Autoimmun; 2016 Jun; 70():40-51. PubMed ID: 27055778
[TBL] [Abstract][Full Text] [Related]
6. Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma.
Bartosińska J; Purkot J; Karczmarczyk A; Chojnacki M; Zaleska J; Własiuk P; Grząśko N; Morawska M; Walter-Croneck A; Usnarska-Zubkiewicz L; Zielińska P; Jamroziak K; Kowal M; Krasowska D; Chodorowska G; Giannopoulos K
Cells; 2021 Feb; 10(2):. PubMed ID: 33669402
[TBL] [Abstract][Full Text] [Related]
7. Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients.
Heinemann K; Wilde B; Hoerning A; Tebbe B; Kribben A; Witzke O; Dolff S
Scand J Rheumatol; 2016 Jul; 45(4):312-6. PubMed ID: 26948375
[TBL] [Abstract][Full Text] [Related]
8. CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer.
Wang WW; Yuan XL; Chen H; Xie GH; Ma YH; Zheng YX; Zhou YL; Shen LS
Oncotarget; 2015 Oct; 6(32):33486-99. PubMed ID: 26378021
[TBL] [Abstract][Full Text] [Related]
9. Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus.
Zhu HQ; Xu RC; Chen YY; Yuan HJ; Cao H; Zhao XQ; Zheng J; Wang Y; Pan M
Br J Dermatol; 2015 Jan; 172(1):101-10. PubMed ID: 24935080
[TBL] [Abstract][Full Text] [Related]
10. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
[TBL] [Abstract][Full Text] [Related]
11. Induction and Differentiation of IL-10-Producing Regulatory B Cells from Healthy Blood Donors and Rheumatoid Arthritis Patients.
Bankó Z; Pozsgay J; Szili D; Tóth M; Gáti T; Nagy G; Rojkovich B; Sármay G
J Immunol; 2017 Feb; 198(4):1512-1520. PubMed ID: 28087671
[TBL] [Abstract][Full Text] [Related]
12. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M
J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071
[TBL] [Abstract][Full Text] [Related]
13. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
14. Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis.
Varghese JF; Kaskow BJ; von Glehn F; Case J; Li Z; Julé AM; Berdan E; Ho Sui SJ; Hu Y; Krishnan R; Chitnis T; Kuchroo VK; Weiner HL; Baecher-Allan CM
Front Immunol; 2024; 15():1360219. PubMed ID: 38745667
[TBL] [Abstract][Full Text] [Related]
15. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
16. The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19
Wang Z; Tan F
Scand J Immunol; 2020 Feb; 91(2):e12836. PubMed ID: 31598989
[TBL] [Abstract][Full Text] [Related]
17. Dysfunction of CD19
Liu Z; Dang E; Li B; Qiao H; Jin L; Zhang J; Wang G
Sci Rep; 2018 Jan; 8(1):703. PubMed ID: 29335495
[TBL] [Abstract][Full Text] [Related]
18. The role of CD19+ CD24high CD38high and CD19+ CD24high CD27+ regulatory B cells in patients with type 1 autoimmune pancreatitis.
Sumimoto K; Uchida K; Kusuda T; Mitsuyama T; Sakaguchi Y; Fukui T; Matsushita M; Takaoka M; Nishio A; Okazaki K
Pancreatology; 2014; 14(3):193-200. PubMed ID: 24854615
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients.
Boldrini VO; Marques AM; Quintiliano RPS; Moraes AS; Stella CRAV; Longhini ALF; Santos I; Andrade M; Ferrari B; Damasceno A; Carneiro RPD; Brandão CO; Farias AS; Santos LMB
Front Immunol; 2022; 13():750660. PubMed ID: 35197967
[TBL] [Abstract][Full Text] [Related]
20. Regulatory Role of B Cells and Its Subsets in Hepatitis E Virus Infection.
Sharma M; Tripathy AS
Biomed Res Int; 2022; 2022():7932150. PubMed ID: 36132083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
